Market Access/ News/ News Napp launches Neulasta biosimilar in UK George Underwood Amgen, biosimilars, Napp, Neulasta 0 Comment Napp’s Pelmeg, a biosimilar of Amgen’s cancer drug Neulasta (pegfilgrastim), has been launched in the UK following approval Share X Napp launches Neulasta biosimilar in UK https://pharmaphorum.com/news/napp-launches-neulasta-biosimilar-in-uk/
Oncology/ Views & Analysis/ Views and analysis Has the NHS joined the biosimilars revolution? Richard Staines biosimilars, Humira, Napp 0 Comment Biosimilars have cut the price of biologic drugs by up to 80% on the NHS, according to Paul Share X Has the NHS joined the biosimilars revolution? https://pharmaphorum.com/oncology/nhs-joined-biosimilar-revolution/
